SlideShare a Scribd company logo
TRANSPORTERS AS TARGETS
FOR DRUGS
P R E S E N T E D B Y : S H I K H A Y . S I N G H
U N D E R T H E G U I D A N C E O F : D R . K B K O T E S H W A R A
D E P A R T M E N T O F P H A R M A C E U T I C S
R E G I S T R A T I O N N O . 1 6 0 6 1 7 0 0 9
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TRANSPORTERS AS TARGETS FOR DRUGS
• INTRODUCTION
• TRANSPORTERS
• TYPES OF TRANSPORTERS
• MEMBRANE TRANSPORT & DRUG RESISTANCE
• PHARMACOKINECTIC PATHWAYS
• CONCLUSION
• REFERENCES
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
2
ManipalCollegeofPharmaceuticalSciences(MCOPS)
CONTENTS
TRANSPORTERS AS TARGETS FOR DRUGS
• WHAT IS BIO-TRANSPORT?
• The movement of drug from one side of the biological barrier to other is called Bio-transport
• The mechanisms involved in transfer of drugs across the biological barrier called Transport
mechanisms
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
3
INTRODUCTION
ManipalCollegeofPharmaceuticalSciences(MCOPS)
4
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
MECHANISM OF MEMBRANE PERMEATION
TRANSPORTERS AS TARGETS FOR DRUGSManipalCollegeofPharmaceuticalSciences(MCOPS)
Transport
Carrier
mediated
Active
primary secondary
Facilitated
Non carrier
mediated
Passive
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
5
ManipalCollegeofPharmaceuticalSciences(MCOPS)
INTRODUCTION
……
TRANSPORTERS AS TARGETS FOR DRUGS
• Transporters are membrane proteins that are present in all organisms
• These proteins controls
• Drug-transporting proteins operate in
 pharmacokinetic pathways
 pharmacodynamic pathways
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
6
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TRANSPORTERS
TRANSPORTERS AS TARGETS FOR DRUGS
Efflux of cellular waste, environmental
toxins, & other xenobiotics
Influx of essential nutrients & ions
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
7
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TYPES OF TRANSPORTERS
• 2000 genes in the human genome (7% of the total number of genes) code for
transporters or transporter-related proteins
• Transporters are of two major superfamilies
TRANSPORTERS AS TARGETS FOR DRUGS
TRANSPORTERS
1.ABC
TRANSPORTERS
1.SLC
TRANSPORTERS
8
TRANSPORTERS AS TARGETS FOR DRUGS
TYPES OF TRANSPORTERS….
1. ATP BINDING CASSETTE TRANSPORTERS
• Most ABC proteins are primary active transporters
• 49 known genes for ABC proteins that can be grouped into 7 subclasses from
ABCA to ABCG
• The best recognized in the ABC superfamily are
I. P-glycoprotein (P-gp encoded by ABCB1, also termed MDR1)
II. Cystic fibrosis transmembrane regulator (CFTR)
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TRANSPORTERS AS TARGETS FOR DRUGS
TYPES OF TRANSPORTERS….
STRUCTURE OF ABC TRANSPORTERS
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
ManipalCollegeofPharmaceuticalSciences(MCOPS)
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
10
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TRANSPORTERS AS TARGETS FOR DRUGS
TYPES OF TRANSPORTERS….
STRUCTURE OF ABC TRANSPORTERS...
• ABC transporter consist of two distinct domains
Transmembrane domain (TMD)
• Membrane-spanning domain (MSD) or Integral membrane
(IM) domain
• Consists of alpha helices, embedded in the membrane bilayer
Nucleotide-binding domain (NBD)
• Site for ATP binding
• Located in the cytoplasm
 EXPORTERS-
N-terminal & C-terminal that are fused as a single polypeptide chain,
Arranged as TMD-NBD-TMD-NBD
 IMPORTERS-
Have an inverted organization i.e NBD-TMD-NBD-TMD
NBD domain is N-terminal whereas TMD is C-terminal
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
11
ManipalCollegeofPharmaceuticalSciences(MCOPS) TRANSPORTERS AS TARGETS FOR DRUGS
TYPES OF TRANSPORTERS….
STRUCTURE OF ABC TRANSPORTERS...
12
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TRANSPORTERS AS TARGETS FOR DRUGS
TYPES OF TRANSPORTERS….
MECHANISM BEHIND ABC TRANSPORTER
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
• As they are Active transporters they require energy in the form of ATP
• Conformational changes in the Transmembrane domain (TMD)
13
GENE NAME FAMILY NAME NO. OF
FAMILIES
DISEASE ASSOCIATED
ABCA ABC A 12 Tangiers dis
Stargadts dis
ABCB ABC B 11 PFIHC
ABCC ABC C 13 Cystic fibrosis
Dubin Johnson syndrome
ABCD ABC D 4 Adreno-leukodystrophy
ABCE ABC E 1
ABCF ABC F 3
ABCG ABC G 5 Sitosterolemia
TRANSPORTERS AS TARGETS FOR DRUGS
TYPES OF TRANSPORTERS….
TYPE OF ABC TRANSPORTERS
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
ManipalCollegeofPharmaceuticalSciences(MCOPS)
1. Alternating-access model
14
ManipalCollegeofPharmaceuticalSciences(MCOPS) TRANSPORTERS AS TARGETS FOR DRUGS
TYPES OF TRANSPORTERS….
ABC TRANSPORTER MODEL
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
15
ManipalCollegeofPharmaceuticalSciences(MCOPS)
2. ATP-Switch model
TRANSPORTERS AS TARGETS FOR DRUGS
TYPES OF TRANSPORTERS….
ABC TRANSPORTER MODEL...
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
16
ManipalCollegeofPharmaceuticalSciences(MCOPS)
ANTICANCER DRUG:
•P-glycoprotein is overexpressed in tumor cells after exposure to cytotoxic
anticancer agents
•P-glycoprotein pumps out the anticancer drugs
•Competitive & allosteric agents are used to inhibit p-gp
TRANSPORTERS AS TARGETS FOR DRUGS
TYPES OF TRANSPORTERS….
ABC TRANSPORTER EXAMPLE
17
TRANSPORTERS AS TARGETS FOR DRUGS
TYPES OF TRANSPORTERS….
2. SOLUTE CARRIER TRANSPORTERS
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
• 48 SLC families with 315 transporters have been identified in the human genome
• SLC subfamily includes
1. Facilitated transporters
2. Ion-coupled secondary active transporters
• It Contain hydrophobic transmembrane alpha helices
• Many serve as drug targets or in drug absorption and disposition
• Most members of the SLC group are located in the cell membrane
• Widely recognized SLC transporters include the serotonin & dopamine transporters
ManipalCollegeofPharmaceuticalSciences(MCOPS)
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
18
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TRANSPORTERS AS TARGETS FOR DRUGS
TYPES OF TRANSPORTERS….
STRUCTURE OF SLC TRANSPORTERS
• Membrane transporters play a critical role in the development of resistance
1. Anticancer drugs
2. Antimicrobial agents
3. Anticonvulsants
• P-glycoprotein is overexpressed in tumor cells after exposure to cytotoxic Anticancer
agents
• The over-expression of MRP4 is associated with resistance to Antiviral nucleoside
analogs
• Tumors arising from tissues where MDR1 is highly expressed show intrinsic resistance
to different Chemotherapeutic agents
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
19
ManipalCollegeofPharmaceuticalSciences(MCOPS)
MEMBRANE TRANSPORT & DRUG
RESISTANCE
TRANSPORTERS AS TARGETS FOR DRUGS
Reversal agents
o 1st Generation- eg cyclosporine, verapamil
o 2nd Generation- eg valspodar, biricodar
o 3rd Generation- eg tariquidar, zosuquidar, laniquidar
Thiomers
o Eg α-Chitosan–thiobutylamidine (chito– TBA)
Nanocarrier drug delivery system
o Liposomes
20
ManipalCollegeofPharmaceuticalSciences(MCOPS)
MEMBRANE TRANSPORT & DRUG RESISTANCE
TRANSPORTERS AS TARGETS FOR DRUGS
NOVEL APPROACHES TO OVERCOME RESISTANCE
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
21
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TRANSPORTERS INVOLVED IN
PHARMACOKINECTICS
TRANSPORTERS AS TARGETS FOR DRUGS
HEPATIC TRANSPORTERS
1. Organic anion transporters- OATPs
2. Organic cation transporters-
o OCTs & NTCP for cations & bile salts
o Uptake either by facilitated or secondary active mechanisms
3. ABC transporters such as MRP2, MDR1, BCRP, BSEP & MDR2-
o Mediate efflux (excretion) of drugs & their metabolites, bile salts &
phospholipids
o Against concentration gradient from liver to bile
o This primary active transport is driven by ATP
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
22
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TRANSPORTERS INVOLVED IN
PHARMACOKINECTICS
TRANSPORTERS AS TARGETS FOR DRUGS
HEPATIC TRANSPORTERS...
1. HMG-COA Reductase inhibitor-
 Statins are cholesterol-lowering agents that reversibly inhibit HMG-CoA
reductase enzyme
2. Temocapril-
 It is an ACE inhibitor temocaprilat & is excreted both in bile & urine whereas
other ACEI’s are excreted mainly via the kidney
3. Irinotecan (CPT-11)-
 It is a potent anticancer drug in late-onset it causes gastrointestinal toxic effects
but after IV administration then excreted into the bile by MRP2
4. Troglitazone
23
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TRANSPORTERS INVOLVED IN
PHARMACOKINECTICS
TRANSPORTERS AS TARGETS FOR DRUGS
DRUGS THAT ACT ON HEPATIC TRANSPORTERS
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
24
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TRANSPORTERS INVOLVED IN
PHARMACOKINECTICS
TRANSPORTERS AS TARGETS FOR DRUGS
RENAL TRANSPORTERS
• Transporters assigned to the apical membrane are in the SLC 22 family
• OCT family involves the uptake of a variety of organic cations
• Drugs that act on OCT are dopamine, choline, N-methylnicotinamide & cimetidine,
ranitidine, metformin, procainamide, and N-acetylprocainamide
• OAT family involves the uptake of a variety of organic anions
• Primary function of organic anion transporters is the removal of xenobiotics include
weak acidic drugs e.g. pravastatin, captopril, pencillins & toxins
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
25
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TRANSPORTERS INVOLVED IN
PHARMACOKINECTICS
TRANSPORTERS AS TARGETS FOR DRUGS
RENAL TRANSPORTERS
 Transporters are needed
To regulate bioavailability
To act as drug targets
To eliminate toxins
To overcome resistance
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of
Pharmaceutics 26
ManipalCollegeofPharmaceuticalSciences(MCOPS)
CONCLUSION
TRANSPORTERS AS TARGETS FOR DRUGS
1. Laurence L. B, Bruce A. C, Bjorn C.K, Goodman & Gillman's The Pharmacological
Basis of Therapeutics, McGraw Hill Education; 12 edition (2011), pp.no: 41-70
2. Cooper.G.M, Hausman .E.R (2009), Transport of small molecules, The cell a
molecular approach (fifth edition) , Boston, Sinauer associates, pp.no: 540-571
3. Tortora.G.J, Derrickson. B (2009), Transport across the plasma membrane,
Principles of anatomy and physiology(twelth edition), John wiley and sons, pp.no:
56-72
4. Rang H & Dale M. (2012). Rang and Dale's pharmacology. Elsevier/ Churchill
Livingstone, Edinburgh, pp.294-304
27
ManipalCollegeofPharmaceuticalSciences(MCOPS)
REFERENCES
TRANSPORTERS AS TARGETS FOR DRUGS
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of
Pharmaceutics
ANY QUERIES???
28
ManipalCollegeofPharmaceuticalSciences(MCOPS) TRANSPORTERS AS TARGETS FOR DRUGS
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of
Pharmaceutics
29
ManipalCollegeofPharmaceuticalSciences(MCOPS)
My sincere thanks to all my respected professors of MCOPS and my
special thanks to Dr. K B Koteshwara sir; without his guidance I would
not be able to put up my presentation to you.
-Shikha Singh (Ist year Mpharm-Industrial Pharmacy)
TRANSPORTERS AS TARGETS FOR DRUGS
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of
Pharmaceutics

More Related Content

What's hot

Membrane transporters and drug response
Membrane transporters and drug responseMembrane transporters and drug response
Membrane transporters and drug response
Soujania Singh
 
Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
Viraj Shinde
 
Non adrenergic, non-cholinergic (nanc) transmitters
Non adrenergic, non-cholinergic (nanc) transmittersNon adrenergic, non-cholinergic (nanc) transmitters
Non adrenergic, non-cholinergic (nanc) transmitters
Rahulvaish13
 
Biosimilars
BiosimilarsBiosimilars
Biosimilars
chandiniyrao
 
Membrane transporters and drug response
Membrane transporters and drug responseMembrane transporters and drug response
Membrane transporters and drug response
Aditi Panditrao
 
Genetics variations in gpcr
Genetics variations in gpcrGenetics variations in gpcr
Genetics variations in gpcr
Deepak Kumar
 
Pharmacogenetics
PharmacogeneticsPharmacogenetics
Pharmacogenetics
souravpharma
 
p-glycoprotein
p-glycoproteinp-glycoprotein
p-glycoprotein
maryam kazemi
 
Pharmacogenomics
Pharmacogenomics Pharmacogenomics
Pharmacogenomics
elsanimadhan
 
Jnk signaling pathway creative diagnostics
Jnk signaling pathway creative diagnosticsJnk signaling pathway creative diagnostics
Jnk signaling pathway creative diagnostics
Creative-Diagnostics
 
Non adrenergic and Non cholinergic transmission
Non adrenergic and Non cholinergic transmission Non adrenergic and Non cholinergic transmission
Non adrenergic and Non cholinergic transmission
E Poovarasan
 
Non adrenergic non cholinergic transmission(nanc)
Non adrenergic non cholinergic transmission(nanc)Non adrenergic non cholinergic transmission(nanc)
Non adrenergic non cholinergic transmission(nanc)
Merlin Binu
 
Relationship between drug concentration and effect and quantitative aspects o...
Relationship between drug concentration and effect and quantitative aspects o...Relationship between drug concentration and effect and quantitative aspects o...
Relationship between drug concentration and effect and quantitative aspects o...
DHINESHKUMAR V
 
Drug receptors
Drug receptorsDrug receptors
Drug receptors
Dr. Shivesh Gupta
 
Cellular and molecular pharmacology
Cellular and molecular pharmacologyCellular and molecular pharmacology
Cellular and molecular pharmacology
SANDEEP MEWADA
 
Michaelis menten kinetics Nonlinear Pharmacokinetics
Michaelis menten kinetics Nonlinear PharmacokineticsMichaelis menten kinetics Nonlinear Pharmacokinetics
Michaelis menten kinetics Nonlinear Pharmacokinetics
Syed Umar Farooq
 
Drug transport
Drug transportDrug transport
Drug transport
Diana Mnoor
 
Cytochrome p450
Cytochrome p450Cytochrome p450
Cytochrome p450
DR.SOUMITRA DAS
 
Regulation of JAK STAT Pathway
Regulation of JAK STAT Pathway Regulation of JAK STAT Pathway
Regulation of JAK STAT Pathway
ZulqarnainHaider86
 

What's hot (20)

Pgp
PgpPgp
Pgp
 
Membrane transporters and drug response
Membrane transporters and drug responseMembrane transporters and drug response
Membrane transporters and drug response
 
Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
 
Non adrenergic, non-cholinergic (nanc) transmitters
Non adrenergic, non-cholinergic (nanc) transmittersNon adrenergic, non-cholinergic (nanc) transmitters
Non adrenergic, non-cholinergic (nanc) transmitters
 
Biosimilars
BiosimilarsBiosimilars
Biosimilars
 
Membrane transporters and drug response
Membrane transporters and drug responseMembrane transporters and drug response
Membrane transporters and drug response
 
Genetics variations in gpcr
Genetics variations in gpcrGenetics variations in gpcr
Genetics variations in gpcr
 
Pharmacogenetics
PharmacogeneticsPharmacogenetics
Pharmacogenetics
 
p-glycoprotein
p-glycoproteinp-glycoprotein
p-glycoprotein
 
Pharmacogenomics
Pharmacogenomics Pharmacogenomics
Pharmacogenomics
 
Jnk signaling pathway creative diagnostics
Jnk signaling pathway creative diagnosticsJnk signaling pathway creative diagnostics
Jnk signaling pathway creative diagnostics
 
Non adrenergic and Non cholinergic transmission
Non adrenergic and Non cholinergic transmission Non adrenergic and Non cholinergic transmission
Non adrenergic and Non cholinergic transmission
 
Non adrenergic non cholinergic transmission(nanc)
Non adrenergic non cholinergic transmission(nanc)Non adrenergic non cholinergic transmission(nanc)
Non adrenergic non cholinergic transmission(nanc)
 
Relationship between drug concentration and effect and quantitative aspects o...
Relationship between drug concentration and effect and quantitative aspects o...Relationship between drug concentration and effect and quantitative aspects o...
Relationship between drug concentration and effect and quantitative aspects o...
 
Drug receptors
Drug receptorsDrug receptors
Drug receptors
 
Cellular and molecular pharmacology
Cellular and molecular pharmacologyCellular and molecular pharmacology
Cellular and molecular pharmacology
 
Michaelis menten kinetics Nonlinear Pharmacokinetics
Michaelis menten kinetics Nonlinear PharmacokineticsMichaelis menten kinetics Nonlinear Pharmacokinetics
Michaelis menten kinetics Nonlinear Pharmacokinetics
 
Drug transport
Drug transportDrug transport
Drug transport
 
Cytochrome p450
Cytochrome p450Cytochrome p450
Cytochrome p450
 
Regulation of JAK STAT Pathway
Regulation of JAK STAT Pathway Regulation of JAK STAT Pathway
Regulation of JAK STAT Pathway
 

Viewers also liked

mbbs ims msu
mbbs ims msumbbs ims msu
mbbs ims msu
MBBS IMS MSU
 
Class newer routes of drug delivery
Class newer routes of drug deliveryClass newer routes of drug delivery
Class newer routes of drug deliveryRaghu Prasada
 
1ères rencontres autour des vigilances sanitaires : Intervention matériovigil...
1ères rencontres autour des vigilances sanitaires : Intervention matériovigil...1ères rencontres autour des vigilances sanitaires : Intervention matériovigil...
1ères rencontres autour des vigilances sanitaires : Intervention matériovigil...
Vigipharm
 
Newer drug delivery systems
Newer  drug delivery systemsNewer  drug delivery systems
Newer drug delivery systems
Mandeep Sarma
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
Sufyan Akram
 
Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomicsshabrelhan
 
newer drug delivery systems
newer drug delivery systemsnewer drug delivery systems
newer drug delivery systems
Novo Nordisk India
 
Medical Devices Postmarket Surveillance 14 jul13
Medical Devices Postmarket Surveillance 14 jul13Medical Devices Postmarket Surveillance 14 jul13
Medical Devices Postmarket Surveillance 14 jul13Annet Visscher
 
9 Karin Heidenreich - Novartis
9 Karin Heidenreich -  Novartis9 Karin Heidenreich -  Novartis
schedule y of drugs and cosmetic acts
schedule y of drugs and cosmetic actsschedule y of drugs and cosmetic acts
schedule y of drugs and cosmetic acts
arponbiswas
 
Smart Drug Delivery Systems
Smart Drug Delivery SystemsSmart Drug Delivery Systems
Smart Drug Delivery Systems
Dolcera Corporation
 
Newer drug delivery methods
Newer drug delivery methodsNewer drug delivery methods
Newer drug delivery methods
Prasheeta V P
 
BIOLOGICALS VS BIOSIMILARS
BIOLOGICALS VS BIOSIMILARSBIOLOGICALS VS BIOSIMILARS
BIOLOGICALS VS BIOSIMILARS
drsureshyerra
 
What Do Doctors Think About Biosimilars?
What Do Doctors Think About Biosimilars?What Do Doctors Think About Biosimilars?
What Do Doctors Think About Biosimilars?
Small World Social
 
Monoclonal antibody and its delivery
Monoclonal antibody and its deliveryMonoclonal antibody and its delivery
Monoclonal antibody and its delivery
shikha singh
 
Different types of Drug Transporters in body By Anubhav Singh M.pharm 1st year
Different types of Drug Transporters in body By Anubhav Singh M.pharm 1st yearDifferent types of Drug Transporters in body By Anubhav Singh M.pharm 1st year
Different types of Drug Transporters in body By Anubhav Singh M.pharm 1st yearAnubhav Singh
 
Fixed dose combination products – rationality, status in india, development i...
Fixed dose combination products – rationality, status in india, development i...Fixed dose combination products – rationality, status in india, development i...
Fixed dose combination products – rationality, status in india, development i...
Dr Sukanta sen
 
Schedule y, mk sharma
Schedule y, mk sharmaSchedule y, mk sharma
Schedule y, mk sharma
SHARDA UNIVERSITY
 
Summary Of Schedule Y
Summary Of Schedule YSummary Of Schedule Y
Summary Of Schedule Ylekshmilnair
 
Postmarket Surveillance Medical Devices
Postmarket Surveillance   Medical DevicesPostmarket Surveillance   Medical Devices
Postmarket Surveillance Medical Devices
Jacobe2008
 

Viewers also liked (20)

mbbs ims msu
mbbs ims msumbbs ims msu
mbbs ims msu
 
Class newer routes of drug delivery
Class newer routes of drug deliveryClass newer routes of drug delivery
Class newer routes of drug delivery
 
1ères rencontres autour des vigilances sanitaires : Intervention matériovigil...
1ères rencontres autour des vigilances sanitaires : Intervention matériovigil...1ères rencontres autour des vigilances sanitaires : Intervention matériovigil...
1ères rencontres autour des vigilances sanitaires : Intervention matériovigil...
 
Newer drug delivery systems
Newer  drug delivery systemsNewer  drug delivery systems
Newer drug delivery systems
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
 
Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
 
newer drug delivery systems
newer drug delivery systemsnewer drug delivery systems
newer drug delivery systems
 
Medical Devices Postmarket Surveillance 14 jul13
Medical Devices Postmarket Surveillance 14 jul13Medical Devices Postmarket Surveillance 14 jul13
Medical Devices Postmarket Surveillance 14 jul13
 
9 Karin Heidenreich - Novartis
9 Karin Heidenreich -  Novartis9 Karin Heidenreich -  Novartis
9 Karin Heidenreich - Novartis
 
schedule y of drugs and cosmetic acts
schedule y of drugs and cosmetic actsschedule y of drugs and cosmetic acts
schedule y of drugs and cosmetic acts
 
Smart Drug Delivery Systems
Smart Drug Delivery SystemsSmart Drug Delivery Systems
Smart Drug Delivery Systems
 
Newer drug delivery methods
Newer drug delivery methodsNewer drug delivery methods
Newer drug delivery methods
 
BIOLOGICALS VS BIOSIMILARS
BIOLOGICALS VS BIOSIMILARSBIOLOGICALS VS BIOSIMILARS
BIOLOGICALS VS BIOSIMILARS
 
What Do Doctors Think About Biosimilars?
What Do Doctors Think About Biosimilars?What Do Doctors Think About Biosimilars?
What Do Doctors Think About Biosimilars?
 
Monoclonal antibody and its delivery
Monoclonal antibody and its deliveryMonoclonal antibody and its delivery
Monoclonal antibody and its delivery
 
Different types of Drug Transporters in body By Anubhav Singh M.pharm 1st year
Different types of Drug Transporters in body By Anubhav Singh M.pharm 1st yearDifferent types of Drug Transporters in body By Anubhav Singh M.pharm 1st year
Different types of Drug Transporters in body By Anubhav Singh M.pharm 1st year
 
Fixed dose combination products – rationality, status in india, development i...
Fixed dose combination products – rationality, status in india, development i...Fixed dose combination products – rationality, status in india, development i...
Fixed dose combination products – rationality, status in india, development i...
 
Schedule y, mk sharma
Schedule y, mk sharmaSchedule y, mk sharma
Schedule y, mk sharma
 
Summary Of Schedule Y
Summary Of Schedule YSummary Of Schedule Y
Summary Of Schedule Y
 
Postmarket Surveillance Medical Devices
Postmarket Surveillance   Medical DevicesPostmarket Surveillance   Medical Devices
Postmarket Surveillance Medical Devices
 

Similar to Transporters as targets for drugs

ACTIVE TRANSPORT Pgp,BCRP,NT.pptx
ACTIVE              TRANSPORT            Pgp,BCRP,NT.pptxACTIVE              TRANSPORT            Pgp,BCRP,NT.pptx
ACTIVE TRANSPORT Pgp,BCRP,NT.pptx
SyedaYameen1
 
computational modeling of drug disposition in active transport M.pharm 2nd se...
computational modeling of drug disposition in active transport M.pharm 2nd se...computational modeling of drug disposition in active transport M.pharm 2nd se...
computational modeling of drug disposition in active transport M.pharm 2nd se...
sakshisoni2385
 
Active transport
Active transportActive transport
Computational modelling of drug disposition active transport
Computational modelling of  drug disposition active transportComputational modelling of  drug disposition active transport
Computational modelling of drug disposition active transport
SUJITHA MARY
 
Membrane transporters
Membrane transportersMembrane transporters
Membrane transporters
Darsana Visakh
 
Transporter superfamilies in the human genome
Transporter superfamilies in the human genomeTransporter superfamilies in the human genome
Transporter superfamilies in the human genome
Akash Agnihotri
 
Active transporter
Active transporter Active transporter
Active transporter
SAKSHI YADAV
 
Genetic Variations in Drug Transporters
Genetic Variations in Drug TransportersGenetic Variations in Drug Transporters
Transporters
TransportersTransporters
Transporters
Ashishkumar Baheti
 
ACTIVE TRANSPORT 1st part.pptx
ACTIVE TRANSPORT 1st part.pptxACTIVE TRANSPORT 1st part.pptx
ACTIVE TRANSPORT 1st part.pptx
PawanDhamala1
 
Pharmacology ADME
Pharmacology ADMEPharmacology ADME
Pharmacology ADME
Yogendra Nayak
 
Pharmacokinetic model & compartment models by Karthickraja M
Pharmacokinetic model & compartment models by Karthickraja MPharmacokinetic model & compartment models by Karthickraja M
Pharmacokinetic model & compartment models by Karthickraja M
Karthick Marimuthu
 
Drug interactions linked to transporters
Drug interactions linked to transportersDrug interactions linked to transporters
Drug interactions linked to transporters
gopinathannsriramachandraeduin
 
19.los transportistas del tracto intestinal y las técnicas que se aplican par...
19.los transportistas del tracto intestinal y las técnicas que se aplican par...19.los transportistas del tracto intestinal y las técnicas que se aplican par...
19.los transportistas del tracto intestinal y las técnicas que se aplican par...
Ever Alonso Rojas Ch
 
Membrane transporters and drug response
Membrane transporters and drug responseMembrane transporters and drug response
Membrane transporters and drug response
bhagyamohod90
 
CAD note by Ms. Pushpa Sahani
CAD note by Ms. Pushpa SahaniCAD note by Ms. Pushpa Sahani
CAD note by Ms. Pushpa Sahani
KpCreation1
 
Active transport
Active transportActive transport
Active transport
suresh gautam
 
Drug transport across cell membrane.
Drug transport across cell membrane.Drug transport across cell membrane.
Drug transport across cell membrane.
Dr. Salman H. Rizvi
 

Similar to Transporters as targets for drugs (20)

ACTIVE TRANSPORT Pgp,BCRP,NT.pptx
ACTIVE              TRANSPORT            Pgp,BCRP,NT.pptxACTIVE              TRANSPORT            Pgp,BCRP,NT.pptx
ACTIVE TRANSPORT Pgp,BCRP,NT.pptx
 
computational modeling of drug disposition in active transport M.pharm 2nd se...
computational modeling of drug disposition in active transport M.pharm 2nd se...computational modeling of drug disposition in active transport M.pharm 2nd se...
computational modeling of drug disposition in active transport M.pharm 2nd se...
 
Active transport
Active transportActive transport
Active transport
 
Computational modelling of drug disposition active transport
Computational modelling of  drug disposition active transportComputational modelling of  drug disposition active transport
Computational modelling of drug disposition active transport
 
Membrane transporters
Membrane transportersMembrane transporters
Membrane transporters
 
Transporter superfamilies in the human genome
Transporter superfamilies in the human genomeTransporter superfamilies in the human genome
Transporter superfamilies in the human genome
 
Active transporter
Active transporter Active transporter
Active transporter
 
Genetic Variations in Drug Transporters
Genetic Variations in Drug TransportersGenetic Variations in Drug Transporters
Genetic Variations in Drug Transporters
 
Transporters
TransportersTransporters
Transporters
 
ACTIVE TRANSPORT 1st part.pptx
ACTIVE TRANSPORT 1st part.pptxACTIVE TRANSPORT 1st part.pptx
ACTIVE TRANSPORT 1st part.pptx
 
Pharmacology ADME
Pharmacology ADMEPharmacology ADME
Pharmacology ADME
 
Pharmacokinetic model & compartment models by Karthickraja M
Pharmacokinetic model & compartment models by Karthickraja MPharmacokinetic model & compartment models by Karthickraja M
Pharmacokinetic model & compartment models by Karthickraja M
 
Drug interactions linked to transporters
Drug interactions linked to transportersDrug interactions linked to transporters
Drug interactions linked to transporters
 
19.los transportistas del tracto intestinal y las técnicas que se aplican par...
19.los transportistas del tracto intestinal y las técnicas que se aplican par...19.los transportistas del tracto intestinal y las técnicas que se aplican par...
19.los transportistas del tracto intestinal y las técnicas que se aplican par...
 
Membrane transporters and drug response
Membrane transporters and drug responseMembrane transporters and drug response
Membrane transporters and drug response
 
Abc seminar
Abc seminarAbc seminar
Abc seminar
 
Abc seminar
Abc seminarAbc seminar
Abc seminar
 
CAD note by Ms. Pushpa Sahani
CAD note by Ms. Pushpa SahaniCAD note by Ms. Pushpa Sahani
CAD note by Ms. Pushpa Sahani
 
Active transport
Active transportActive transport
Active transport
 
Drug transport across cell membrane.
Drug transport across cell membrane.Drug transport across cell membrane.
Drug transport across cell membrane.
 

More from shikha singh

Body powder - Cosmetology
Body powder - CosmetologyBody powder - Cosmetology
Body powder - Cosmetology
shikha singh
 
Approaches for delivery of protein, peptides & vaccines
Approaches for delivery of protein, peptides & vaccinesApproaches for delivery of protein, peptides & vaccines
Approaches for delivery of protein, peptides & vaccines
shikha singh
 
Biowaivers
BiowaiversBiowaivers
Biowaivers
shikha singh
 
Measurement of bioavailability
Measurement of bioavailabilityMeasurement of bioavailability
Measurement of bioavailability
shikha singh
 
Biosimilars
BiosimilarsBiosimilars
Biosimilars
shikha singh
 
Formulation factors affecting drug absorption
Formulation factors affecting drug absorptionFormulation factors affecting drug absorption
Formulation factors affecting drug absorption
shikha singh
 
Pilot plant for tablet dosage form
Pilot plant for tablet dosage formPilot plant for tablet dosage form
Pilot plant for tablet dosage form
shikha singh
 
Vendor development in pharmaceutical industry
Vendor development in pharmaceutical industryVendor development in pharmaceutical industry
Vendor development in pharmaceutical industry
shikha singh
 
Factor influence the selection of plant location
Factor influence the selection of  plant locationFactor influence the selection of  plant location
Factor influence the selection of plant location
shikha singh
 
Competency level in pharmaceutical industries
Competency level in pharmaceutical industriesCompetency level in pharmaceutical industries
Competency level in pharmaceutical industries
shikha singh
 
The need for continual training program as a part of cGMP in pharmaceutical i...
The need for continual training program as a part of cGMP in pharmaceutical i...The need for continual training program as a part of cGMP in pharmaceutical i...
The need for continual training program as a part of cGMP in pharmaceutical i...
shikha singh
 
ETHOSOMES AS NOVEL DRUG DELIVERY
ETHOSOMES AS NOVEL DRUG DELIVERYETHOSOMES AS NOVEL DRUG DELIVERY
ETHOSOMES AS NOVEL DRUG DELIVERY
shikha singh
 

More from shikha singh (12)

Body powder - Cosmetology
Body powder - CosmetologyBody powder - Cosmetology
Body powder - Cosmetology
 
Approaches for delivery of protein, peptides & vaccines
Approaches for delivery of protein, peptides & vaccinesApproaches for delivery of protein, peptides & vaccines
Approaches for delivery of protein, peptides & vaccines
 
Biowaivers
BiowaiversBiowaivers
Biowaivers
 
Measurement of bioavailability
Measurement of bioavailabilityMeasurement of bioavailability
Measurement of bioavailability
 
Biosimilars
BiosimilarsBiosimilars
Biosimilars
 
Formulation factors affecting drug absorption
Formulation factors affecting drug absorptionFormulation factors affecting drug absorption
Formulation factors affecting drug absorption
 
Pilot plant for tablet dosage form
Pilot plant for tablet dosage formPilot plant for tablet dosage form
Pilot plant for tablet dosage form
 
Vendor development in pharmaceutical industry
Vendor development in pharmaceutical industryVendor development in pharmaceutical industry
Vendor development in pharmaceutical industry
 
Factor influence the selection of plant location
Factor influence the selection of  plant locationFactor influence the selection of  plant location
Factor influence the selection of plant location
 
Competency level in pharmaceutical industries
Competency level in pharmaceutical industriesCompetency level in pharmaceutical industries
Competency level in pharmaceutical industries
 
The need for continual training program as a part of cGMP in pharmaceutical i...
The need for continual training program as a part of cGMP in pharmaceutical i...The need for continual training program as a part of cGMP in pharmaceutical i...
The need for continual training program as a part of cGMP in pharmaceutical i...
 
ETHOSOMES AS NOVEL DRUG DELIVERY
ETHOSOMES AS NOVEL DRUG DELIVERYETHOSOMES AS NOVEL DRUG DELIVERY
ETHOSOMES AS NOVEL DRUG DELIVERY
 

Recently uploaded

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 

Transporters as targets for drugs

  • 1. TRANSPORTERS AS TARGETS FOR DRUGS P R E S E N T E D B Y : S H I K H A Y . S I N G H U N D E R T H E G U I D A N C E O F : D R . K B K O T E S H W A R A D E P A R T M E N T O F P H A R M A C E U T I C S R E G I S T R A T I O N N O . 1 6 0 6 1 7 0 0 9 ManipalCollegeofPharmaceuticalSciences(MCOPS)
  • 2. TRANSPORTERS AS TARGETS FOR DRUGS • INTRODUCTION • TRANSPORTERS • TYPES OF TRANSPORTERS • MEMBRANE TRANSPORT & DRUG RESISTANCE • PHARMACOKINECTIC PATHWAYS • CONCLUSION • REFERENCES Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics 2 ManipalCollegeofPharmaceuticalSciences(MCOPS) CONTENTS
  • 3. TRANSPORTERS AS TARGETS FOR DRUGS • WHAT IS BIO-TRANSPORT? • The movement of drug from one side of the biological barrier to other is called Bio-transport • The mechanisms involved in transfer of drugs across the biological barrier called Transport mechanisms Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics 3 INTRODUCTION ManipalCollegeofPharmaceuticalSciences(MCOPS)
  • 4. 4 Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics MECHANISM OF MEMBRANE PERMEATION TRANSPORTERS AS TARGETS FOR DRUGSManipalCollegeofPharmaceuticalSciences(MCOPS)
  • 5. Transport Carrier mediated Active primary secondary Facilitated Non carrier mediated Passive Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics 5 ManipalCollegeofPharmaceuticalSciences(MCOPS) INTRODUCTION …… TRANSPORTERS AS TARGETS FOR DRUGS
  • 6. • Transporters are membrane proteins that are present in all organisms • These proteins controls • Drug-transporting proteins operate in  pharmacokinetic pathways  pharmacodynamic pathways Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics 6 ManipalCollegeofPharmaceuticalSciences(MCOPS) TRANSPORTERS TRANSPORTERS AS TARGETS FOR DRUGS Efflux of cellular waste, environmental toxins, & other xenobiotics Influx of essential nutrients & ions
  • 7. Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics 7 ManipalCollegeofPharmaceuticalSciences(MCOPS) TYPES OF TRANSPORTERS • 2000 genes in the human genome (7% of the total number of genes) code for transporters or transporter-related proteins • Transporters are of two major superfamilies TRANSPORTERS AS TARGETS FOR DRUGS TRANSPORTERS 1.ABC TRANSPORTERS 1.SLC TRANSPORTERS
  • 8. 8 TRANSPORTERS AS TARGETS FOR DRUGS TYPES OF TRANSPORTERS…. 1. ATP BINDING CASSETTE TRANSPORTERS • Most ABC proteins are primary active transporters • 49 known genes for ABC proteins that can be grouped into 7 subclasses from ABCA to ABCG • The best recognized in the ABC superfamily are I. P-glycoprotein (P-gp encoded by ABCB1, also termed MDR1) II. Cystic fibrosis transmembrane regulator (CFTR) Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics ManipalCollegeofPharmaceuticalSciences(MCOPS)
  • 9. TRANSPORTERS AS TARGETS FOR DRUGS TYPES OF TRANSPORTERS…. STRUCTURE OF ABC TRANSPORTERS Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics ManipalCollegeofPharmaceuticalSciences(MCOPS)
  • 10. Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics 10 ManipalCollegeofPharmaceuticalSciences(MCOPS) TRANSPORTERS AS TARGETS FOR DRUGS TYPES OF TRANSPORTERS…. STRUCTURE OF ABC TRANSPORTERS... • ABC transporter consist of two distinct domains Transmembrane domain (TMD) • Membrane-spanning domain (MSD) or Integral membrane (IM) domain • Consists of alpha helices, embedded in the membrane bilayer Nucleotide-binding domain (NBD) • Site for ATP binding • Located in the cytoplasm
  • 11.  EXPORTERS- N-terminal & C-terminal that are fused as a single polypeptide chain, Arranged as TMD-NBD-TMD-NBD  IMPORTERS- Have an inverted organization i.e NBD-TMD-NBD-TMD NBD domain is N-terminal whereas TMD is C-terminal Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics 11 ManipalCollegeofPharmaceuticalSciences(MCOPS) TRANSPORTERS AS TARGETS FOR DRUGS TYPES OF TRANSPORTERS…. STRUCTURE OF ABC TRANSPORTERS...
  • 12. 12 ManipalCollegeofPharmaceuticalSciences(MCOPS) TRANSPORTERS AS TARGETS FOR DRUGS TYPES OF TRANSPORTERS…. MECHANISM BEHIND ABC TRANSPORTER Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics • As they are Active transporters they require energy in the form of ATP • Conformational changes in the Transmembrane domain (TMD)
  • 13. 13 GENE NAME FAMILY NAME NO. OF FAMILIES DISEASE ASSOCIATED ABCA ABC A 12 Tangiers dis Stargadts dis ABCB ABC B 11 PFIHC ABCC ABC C 13 Cystic fibrosis Dubin Johnson syndrome ABCD ABC D 4 Adreno-leukodystrophy ABCE ABC E 1 ABCF ABC F 3 ABCG ABC G 5 Sitosterolemia TRANSPORTERS AS TARGETS FOR DRUGS TYPES OF TRANSPORTERS…. TYPE OF ABC TRANSPORTERS Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics ManipalCollegeofPharmaceuticalSciences(MCOPS)
  • 14. 1. Alternating-access model 14 ManipalCollegeofPharmaceuticalSciences(MCOPS) TRANSPORTERS AS TARGETS FOR DRUGS TYPES OF TRANSPORTERS…. ABC TRANSPORTER MODEL Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
  • 15. 15 ManipalCollegeofPharmaceuticalSciences(MCOPS) 2. ATP-Switch model TRANSPORTERS AS TARGETS FOR DRUGS TYPES OF TRANSPORTERS…. ABC TRANSPORTER MODEL... Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
  • 16. Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics 16 ManipalCollegeofPharmaceuticalSciences(MCOPS) ANTICANCER DRUG: •P-glycoprotein is overexpressed in tumor cells after exposure to cytotoxic anticancer agents •P-glycoprotein pumps out the anticancer drugs •Competitive & allosteric agents are used to inhibit p-gp TRANSPORTERS AS TARGETS FOR DRUGS TYPES OF TRANSPORTERS…. ABC TRANSPORTER EXAMPLE
  • 17. 17 TRANSPORTERS AS TARGETS FOR DRUGS TYPES OF TRANSPORTERS…. 2. SOLUTE CARRIER TRANSPORTERS Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics • 48 SLC families with 315 transporters have been identified in the human genome • SLC subfamily includes 1. Facilitated transporters 2. Ion-coupled secondary active transporters • It Contain hydrophobic transmembrane alpha helices • Many serve as drug targets or in drug absorption and disposition • Most members of the SLC group are located in the cell membrane • Widely recognized SLC transporters include the serotonin & dopamine transporters ManipalCollegeofPharmaceuticalSciences(MCOPS)
  • 18. Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics 18 ManipalCollegeofPharmaceuticalSciences(MCOPS) TRANSPORTERS AS TARGETS FOR DRUGS TYPES OF TRANSPORTERS…. STRUCTURE OF SLC TRANSPORTERS
  • 19. • Membrane transporters play a critical role in the development of resistance 1. Anticancer drugs 2. Antimicrobial agents 3. Anticonvulsants • P-glycoprotein is overexpressed in tumor cells after exposure to cytotoxic Anticancer agents • The over-expression of MRP4 is associated with resistance to Antiviral nucleoside analogs • Tumors arising from tissues where MDR1 is highly expressed show intrinsic resistance to different Chemotherapeutic agents Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics 19 ManipalCollegeofPharmaceuticalSciences(MCOPS) MEMBRANE TRANSPORT & DRUG RESISTANCE TRANSPORTERS AS TARGETS FOR DRUGS
  • 20. Reversal agents o 1st Generation- eg cyclosporine, verapamil o 2nd Generation- eg valspodar, biricodar o 3rd Generation- eg tariquidar, zosuquidar, laniquidar Thiomers o Eg α-Chitosan–thiobutylamidine (chito– TBA) Nanocarrier drug delivery system o Liposomes 20 ManipalCollegeofPharmaceuticalSciences(MCOPS) MEMBRANE TRANSPORT & DRUG RESISTANCE TRANSPORTERS AS TARGETS FOR DRUGS NOVEL APPROACHES TO OVERCOME RESISTANCE Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
  • 21. Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics 21 ManipalCollegeofPharmaceuticalSciences(MCOPS) TRANSPORTERS INVOLVED IN PHARMACOKINECTICS TRANSPORTERS AS TARGETS FOR DRUGS HEPATIC TRANSPORTERS 1. Organic anion transporters- OATPs 2. Organic cation transporters- o OCTs & NTCP for cations & bile salts o Uptake either by facilitated or secondary active mechanisms 3. ABC transporters such as MRP2, MDR1, BCRP, BSEP & MDR2- o Mediate efflux (excretion) of drugs & their metabolites, bile salts & phospholipids o Against concentration gradient from liver to bile o This primary active transport is driven by ATP
  • 22. Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics 22 ManipalCollegeofPharmaceuticalSciences(MCOPS) TRANSPORTERS INVOLVED IN PHARMACOKINECTICS TRANSPORTERS AS TARGETS FOR DRUGS HEPATIC TRANSPORTERS...
  • 23. 1. HMG-COA Reductase inhibitor-  Statins are cholesterol-lowering agents that reversibly inhibit HMG-CoA reductase enzyme 2. Temocapril-  It is an ACE inhibitor temocaprilat & is excreted both in bile & urine whereas other ACEI’s are excreted mainly via the kidney 3. Irinotecan (CPT-11)-  It is a potent anticancer drug in late-onset it causes gastrointestinal toxic effects but after IV administration then excreted into the bile by MRP2 4. Troglitazone 23 ManipalCollegeofPharmaceuticalSciences(MCOPS) TRANSPORTERS INVOLVED IN PHARMACOKINECTICS TRANSPORTERS AS TARGETS FOR DRUGS DRUGS THAT ACT ON HEPATIC TRANSPORTERS Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
  • 24. Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics 24 ManipalCollegeofPharmaceuticalSciences(MCOPS) TRANSPORTERS INVOLVED IN PHARMACOKINECTICS TRANSPORTERS AS TARGETS FOR DRUGS RENAL TRANSPORTERS
  • 25. • Transporters assigned to the apical membrane are in the SLC 22 family • OCT family involves the uptake of a variety of organic cations • Drugs that act on OCT are dopamine, choline, N-methylnicotinamide & cimetidine, ranitidine, metformin, procainamide, and N-acetylprocainamide • OAT family involves the uptake of a variety of organic anions • Primary function of organic anion transporters is the removal of xenobiotics include weak acidic drugs e.g. pravastatin, captopril, pencillins & toxins Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics 25 ManipalCollegeofPharmaceuticalSciences(MCOPS) TRANSPORTERS INVOLVED IN PHARMACOKINECTICS TRANSPORTERS AS TARGETS FOR DRUGS RENAL TRANSPORTERS
  • 26.  Transporters are needed To regulate bioavailability To act as drug targets To eliminate toxins To overcome resistance Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics 26 ManipalCollegeofPharmaceuticalSciences(MCOPS) CONCLUSION TRANSPORTERS AS TARGETS FOR DRUGS
  • 27. 1. Laurence L. B, Bruce A. C, Bjorn C.K, Goodman & Gillman's The Pharmacological Basis of Therapeutics, McGraw Hill Education; 12 edition (2011), pp.no: 41-70 2. Cooper.G.M, Hausman .E.R (2009), Transport of small molecules, The cell a molecular approach (fifth edition) , Boston, Sinauer associates, pp.no: 540-571 3. Tortora.G.J, Derrickson. B (2009), Transport across the plasma membrane, Principles of anatomy and physiology(twelth edition), John wiley and sons, pp.no: 56-72 4. Rang H & Dale M. (2012). Rang and Dale's pharmacology. Elsevier/ Churchill Livingstone, Edinburgh, pp.294-304 27 ManipalCollegeofPharmaceuticalSciences(MCOPS) REFERENCES TRANSPORTERS AS TARGETS FOR DRUGS Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
  • 28. ANY QUERIES??? 28 ManipalCollegeofPharmaceuticalSciences(MCOPS) TRANSPORTERS AS TARGETS FOR DRUGS Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
  • 29. 29 ManipalCollegeofPharmaceuticalSciences(MCOPS) My sincere thanks to all my respected professors of MCOPS and my special thanks to Dr. K B Koteshwara sir; without his guidance I would not be able to put up my presentation to you. -Shikha Singh (Ist year Mpharm-Industrial Pharmacy) TRANSPORTERS AS TARGETS FOR DRUGS Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics

Editor's Notes

  1. Secondary- no atp coupling potential difference is used to pump out of the cell Facilitated conc gradient
  2. Regulating the distribution and bioavailability of drugs
  3. Genes gives function to d transporters
  4. Atp coupled n & c terminal changes depending upon the transport
  5.  Both ABC importers and exporters have a common mechanism in transporting substrates because of the similarities in their structures.
  6. For importers, In this outward-facing conformation will have higher binding affinity for substrate. since translocation is directed from the periplasm to the cytoplasm. For exporters, In this inward-facing conformation will have higher binding affinity for substrate. since translocation is directed from the cytoplasm to the periplasm
  7. This model presents 2 principal conformation of the NBDs Formation of a A closed dimer on binding of the 2 ATP molecules Dissociation to an open dimer facilitated by the ATP hydrolysis Switching between the 2 conformations induces a conformational change in the TMD resulting in substrate translocation
  8. (SERT, encoded by SLC6A4; DAT, encoded by SLC6A3). Located in cell membrane Secondary- no atp coupling potential difference is used to pump out of the cell Facilitated conc gradient No energy required widely used in d brain
  9. multidrug-resistance protein
  10. Liposomes me phospholipid get sacrifice Thiol grp pgp inhibitor Competitive inhibitors